News

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices
Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.
Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say
The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...
Ozempic, Botox, Eliquis: How Tariffs on Europe Could Impact Drug Prices (And What To Do About It)
With approximately 60% of prescription drugs coming from Europe, including major brands like Ozempic, Botox and Eliquis, many ...
STAT3d
The murkiness of drug companies’ price transparency reports
Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that ...
The Commonwealth Fund1d
The 340B Drug Pricing Program: How It Works and Why It’s Controversial
The 340B Drug Pricing Program was created to improve access to care at safety-net hospitals and clinics, but critics argue ...
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
Little-known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed savings.
MedPage Today on MSN2d
Why Are Drug Prices So High? PBMs Are Only Part of the Answer, Say GOP Advisers
Problems in the prescription drug marketplace such as lack of transparency "are compounded by the labyrinth of regulations ...